1. Home
  2. CAE vs AXSM Comparison

CAE vs AXSM Comparison

Compare CAE & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$23.15

Market Cap

10.1B

Sector

N/A

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$236.07

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
AXSM
Founded
1947
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
12.0B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
CAE
AXSM
Price
$23.15
$236.07
Analyst Decision
Buy
Strong Buy
Analyst Count
3
17
Target Price
$33.33
$211.12
AVG Volume (30 Days)
701.7K
811.6K
Earning Date
05-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.97
$57.24
Revenue Next Year
N/A
$55.88
P/E Ratio
$35.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.63
$96.09
52 Week High
$34.24
$235.92

Technical Indicators

Market Signals
Indicator
CAE
AXSM
Relative Strength Index (RSI) 30.19 73.42
Support Level N/A $179.00
Resistance Level $27.96 N/A
Average True Range (ATR) 0.76 7.06
MACD -0.10 -0.03
Stochastic Oscillator 8.46 95.81

Price Performance

Historical Comparison
CAE
AXSM

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: